5月19日至5月23日，世界骨腫瘤大師Donati教授再次到訪深圳市第二人民醫(yī)院擔(dān)任國際客座教授。Donati教授所就職的意大利里佐利骨科研究所，在2025年，被美國新聞周刊評選為世界十大著名骨科機構(gòu)，其在骨與軟組織腫瘤治療方面已有一百多年的歷史，是歐洲乃至世界最著名的骨腫瘤中心。在一周的交流里，Donati教授在骨關(guān)節(jié)骨腫瘤外科孫煒主任及其帶領(lǐng)下的骨腫瘤團隊李偉主任、鄭傳禧醫(yī)師、徐剛醫(yī)師陪同下，通過門診查房、手術(shù)指導(dǎo)、疑難病例討論、科室管理培訓(xùn)、大師公開課等形式繼續(xù)深入分享里佐利骨科研究所骨與軟組織腫瘤的診療理念以及臨床經(jīng)驗。此次與骨腫瘤團隊的學(xué)術(shù)交流不僅是對于某個細節(jié)問題或者單純的手術(shù)技術(shù)的討論，更多聚焦在骨腫瘤中心的搭建、骨腫瘤?？迫瞬诺呐囵B(yǎng)以及多學(xué)科團隊協(xié)作等問題的探討。Donati教授強調(diào)這三方面是衡量一個地區(qū)可提供專業(yè)化骨腫瘤診療的關(guān)鍵因素，是需要當(dāng)?shù)卣?、醫(yī)院領(lǐng)導(dǎo)層以及外科醫(yī)生和相關(guān)醫(yī)護人員共同努力去提升的。骨腫瘤手術(shù)與骨科手術(shù)完全不同，其診療的理念也完全不同，骨腫瘤外科醫(yī)生不僅要學(xué)會當(dāng)一名外科醫(yī)生還需要學(xué)會當(dāng)一名骨腫瘤科學(xué)家，這就需要其學(xué)習(xí)腫瘤知識、積累豐富的骨腫瘤治療經(jīng)驗并相應(yīng)開展大量的科學(xué)研究，才能夠成長為合格的骨腫瘤外科醫(yī)生；而一個良好運作的骨腫瘤中心，除了需配備相關(guān)醫(yī)療設(shè)備外，需要有一個經(jīng)驗豐富的骨腫瘤多學(xué)科團隊，包括骨腫瘤外科醫(yī)生、病理學(xué)家、腫瘤內(nèi)科專家、影像科專家、放射科專家等。參照歐洲的骨腫瘤中心數(shù)量以及骨腫瘤的發(fā)病率，一個地區(qū)里每1000萬人口需要有一個骨腫瘤中心。深圳市目前約有1700萬人口，建立兩個骨腫瘤中心就可滿足當(dāng)?shù)毓悄[瘤病人的需求。因此，Donati教授建議當(dāng)?shù)毓悄[瘤病人可匯集到一到兩個骨腫瘤中心進行治療，而不是分散到當(dāng)?shù)馗骷裔t(yī)院進行治療。因為通過積累大量骨腫瘤的診療經(jīng)驗，這不僅有利于搭建一個專業(yè)化的骨腫瘤多學(xué)科團隊，也便于進行科學(xué)研究。訪問結(jié)束的最后一天，深圳市二骨腫瘤團隊全員送別Donati教授，對其一周的指導(dǎo)與分享表示誠摯的感謝。明年3月深圳市二將會派出一名青年醫(yī)生到訪里佐利骨科研究所骨腫瘤科訪問學(xué)習(xí)，學(xué)成歸國后，希望能夠引進更多國外先進的理念，為當(dāng)?shù)卮罱▽I(yè)化的骨腫瘤中心貢獻一份力量。

From May 19th to May 23rd, Prof. Donati, the World-class Master on Bone Tumor, visited Shenzhen Second People's Hospital for the second time as an international visiting professor. he Rizzoli Orthopaedic Institute in Italy, where Prof. Donati works, is ranked as one of the top ten orthopaedic institutions in the world by Newsweek in 2025.It has a history of over 100 years in the treatment of bone and soft tissue tumors, and is recognized as the most famous bone tumor center in Europe and even around the world. During the one-week visit, Prof. Donati, accompanied by SUN Wei, Director of Department of Bone and Joint Surgery and Musculoskeletal Tumor Surgery and Director LI Wei, Dr. ZHENG Chuanxi and Dr. XU Gang from the bone tumor team, continued to share the diagnosis and treatment concepts and clinical experiences in bone and soft tissue tumors of Rizzoli Orthopaedic Institute through a series of activities, like outpatient clinics and ward round, surgical guidance, discussion of difficult cases, training on department management and public lecture, etc. he academic exchanges with the bone tumor team were not only about discussing a specific point or purely surgical techniques, but also focused on the establishment of bone tumor center, the training of bone tumor surgeon, and multidisciplinary collaboration, etc. Prof. Donati pointed out that these are the three key factors to evaluate the capability of providing professional treatment for bone tumor patients in a region. And the improvement of them needs to be addressed by the local government, the leaders of hospitals, as well as surgeons and related medical staffs in a joint effort. Bone tumor surgery is completely different from orthopedic surgery, and its diagnosis and treatment concepts are also a totally different thing. one tumor surgeons should not only learn to be a surgeon, but also should learn to be a scientist in bone oncology. his requires them to learn knowledge about oncology, accumulate extensive experience in treating bone tumors, and conduct a large amount of scientific research, in this way they could grow to be a qualified bone tumor surgeon; In addition to be equipped with medical equipment, a well-functioning bone tumor center requires an experienced multidisciplinary bone tumor team, including bone tumor surgeons, pathologists, medical oncologists, imaging specialists, radiologists, and so on. With reference to the number of bone tumor centers in Europe and the incidence rate of bone tumors, one bone tumor center is needed for a region with a population of 10 million people. Shenzhen, with a current population of approximately 17 million, would require the establishment of two bone tumor centers to adequately meet the clinical needs of local patients with bone tumors. Therefore, Prof. Donati suggested that the local bone tumor patients can be collected and sent to one or two bone tumor centers in Shenzhen for treatment, instead of being treated in different local hospitals. Because this approach allows for the accumulation of extensive clinical experience in bone tumor treatment, which not only facilitates the development of a specialized multidisciplinary team focused on bone tumors but also enhances scientific research capabilities. n the last day of the visit, the whole bone tumor team of Shenzhen Second People's Hospital sent Prof. Donati off and expressed their sincere thankfulness for his one-week guidance and sharing. In March 2026, Shenzhen Second People's Hospital will send a young doctor to visit the Department of Orthopaedic Oncology of Rizzoli Orthopaedic Institute for fellowship. fter returning home, we hope that he could bring more advanced concepts from abroad and contribute to the building of a specialized bone tumor center in the region.